US stock futures were edging lower Monday after President Donald Trump slammed Iran's response to a U.S. peace proposal.
These stocks were making moves in premarket trading:
Moderna jumped 9.5%, making the vaccine maker the S&P 500's best performer ahead of the opening bell. Shares rallied after the U.S. health department said one passenger on a repatriation flight had tested mildly positive for the Andes strain of hantavirus, while another is currently experiencing mild symptoms. Moderna said in a statement last week it was working on an "early-stage and ongoing" treatment for hantavirus.
Micron Technology rose 3.3% and SK Hynix surged 12% as rival memory-chip maker Samsung Electronics and its labor union held post-mediation talks in a final effort to reach a settlement and avoid a general walkout. The strike could hit about 3% of global memory-chip production, according to Jefferies.
Intel jumped 6.6% to $133.10, after closing 14% higher on Friday following a report that said the chip maker had reached a preliminary agreement to manufacture some chips for Apple devices. Bank of America on Monday raised its price target on the stock to $96 from $56 but maintained its Underperform rating.
Lumentum shares rose 4.9% in premarket trading as the company will join the Nasdaq-100 Index on May 18, 2026, replacing CoStar.
Apollo Global Management slipped 0.9% after The Wall Street Journal reported it was in talks to sell one of its private-credit funds, citing people familiar with the matter. Apollo didn't immediately respond to a request for comment from Barron's.
Circle on Monday reported higher quarterly revenue and reserve income driven by increased adoption and circulation of its stablecoin, sending its shares rising nearly 3% in trading before the bell.
